162 related articles for article (PubMed ID: 17203171)
1. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance.
Tomizawa M; Horie H; Yamamoto H; Matsunaga T; Sasaki F; Hashizume K; Hiyama E; Kaneko M; Suita S; Ando H; Hayashi Y; Ohnuma N; Nakagawara A
Oncol Rep; 2007 Feb; 17(2):341-4. PubMed ID: 17203171
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
Tomizawa M; Watanabe K; Saisho H; Nakagawara A; Tagawa M
Anticancer Res; 2003; 23(1A):351-4. PubMed ID: 12680236
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of the CCAAT/enhancer binding protein alpha gene involved in hepatocyte proliferation in human hepatocellular carcinomas.
Tomizawa M; Wang YQ; Ebara M; Saisho H; Watanabe K; Nakagawara A; Tagawa M
Int J Mol Med; 2002 Jun; 9(6):597-600. PubMed ID: 12011976
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
Halmos B; Huettner CS; Kocher O; Ferenczi K; Karp DD; Tenen DG
Cancer Res; 2002 Jan; 62(2):528-34. PubMed ID: 11809705
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
8. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.
Ahdjoudj S; Kaabeche K; Holy X; Fromigué O; Modrowski D; Zérath E; Marie PJ
Exp Cell Res; 2005 Feb; 303(1):138-47. PubMed ID: 15572034
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
[TBL] [Abstract][Full Text] [Related]
12. Essential requirement of CCAAT/enhancer binding proteins in embryogenesis.
Bégay V; Smink J; Leutz A
Mol Cell Biol; 2004 Nov; 24(22):9744-51. PubMed ID: 15509779
[TBL] [Abstract][Full Text] [Related]
13. Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli.
Pérez-Capote K; Saura J; Serratosa J; Solà C
Neurosci Lett; 2006 Dec; 410(1):25-30. PubMed ID: 17070994
[TBL] [Abstract][Full Text] [Related]
14. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
[TBL] [Abstract][Full Text] [Related]
16. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression.
Sundfeldt K; Ivarsson K; Carlsson M; Enerbäck S; Janson PO; Brännström M; Hedin L
Br J Cancer; 1999 Mar; 79(7-8):1240-8. PubMed ID: 10098766
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis.
Hayashida M; Okazaki K; Fukushi J; Sakamoto A; Iwamoto Y
Arthritis Rheum; 2009 Mar; 60(3):708-16. PubMed ID: 19248099
[TBL] [Abstract][Full Text] [Related]
19. FMIP controls the adipocyte lineage commitment of C2C12 cells by downmodulation of C/EBP alpha.
Mancini A; El Bounkari O; Norrenbrock AF; Scherr M; Schaefer D; Eder M; Banham AH; Pulford K; Lyne L; Whetton AD; Tamura T
Oncogene; 2007 Feb; 26(7):1020-7. PubMed ID: 16909111
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
Wang W; Bergh A; Damber JE
Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
